A Study of YM178 in Patients With Symptomatic Overactive Bladder (DRAGON)

Clinical trial NCT00337090 · COMPLETED

Trial details

NCT number: NCT00337090
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Overactive Bladder

Primary completion: 2007-03-01
Enrollment: 1108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.